Navigation Links
DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller
Date:7/7/2009

PRINCETON, N.J., July 7 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, announced today that it recently appointed Christopher P. Schnittker, CPA as its new Vice President of Administration and Controller. In this role, Mr. Schnittker will oversee the Accounting, Human Resources, and Administrative functions, as well as serve as the Company's Principal Accounting Officer for SEC reporting purposes.

Mr. Schnittker comes to DOR with more than 18 years of financial management experience primarily in publicly held life science companies. Prior to joining DOR, he served in the senior financial roles for VioQuest Pharmaceuticals Inc., Micromet Inc., Cytogen Corporation and Genaera Corporation, all publicly traded, R&D-focused companies in the biotechnology and specialty pharmaceuticals arenas. Mr. Schnittker also held management positions in accounting, reporting and auditing at GSI Commerce, Rhone-Poulenc Rorer (now part of Sanofi-Aventis), and PricewaterhouseCoopers. He received his Bachelor's degree in Economics and Business with a concentration in Accounting from Lafayette College and is a Certified Public Accountant currently licensed in the State of New Jersey.

"I am very excited to be joining DOR at this point in its development. The remainder of 2009 promises to be a significant step forward with the initiation of the Company's confirmatory Phase 3 trial for orBec(R), as well as the achievement of important development milestones in other key programs," stated Mr. Schnittker.

"We are very pleased to welcome Christopher to the DOR team," said Evan Myrianthopoulos, Chief Financial Officer of DOR. "His experience with development stage and commercialized biotech and pharmaceutical companies will serve us well in preparation for our increased clinical trial activities in the latter half of this year and goin
'/>"/>

SOURCE DOR BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
2. Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
3. Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series
4. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
5. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
6. PDL BioPharma Announces Record Date for October 1 Dividend Payment
7. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
8. SAFE-BioPharma Webinar Featuring ARX's Digital Signatures Combined with Microsoft SharePoint for Bio-Pharma industry
9. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
10. The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate
11. SAFE-BioPharma Webinar Featuring ARX's Digital Signature Solution and Adobe LiveCycle Combined Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... NY (PRWEB) , ... August 01, 2015 , ... On ... cyberespionage group , who are thought to have been behind the attack on Anthem ... topics covered were zero day exploits, watering hole attacks and spear phishing campaigns. ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s ... What are the STASH awards? The Significant Technological Achievements in Secretive Horticulture (or ... as well as tried-and-true products that have stood the test of time. These ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a ... going on in Chicago at Grant Park. The festival will end on Sunday, ... America to Chicago for the annual Lollapalooza. This unique and unbelievably popular festival ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade ... outer thighs. The original applicator required a 2 hour treatment time. The ...
(Date:7/31/2015)... Washington, PA (PRWEB) , ... July 31, 2015 , ... ... specialties, is excited to launch three new Board Exam Courses. , The additions ... Smartest Doc Board Exam Prep from MDLinx makes preparing for the exam easy and ...
Breaking Medicine News(10 mins):Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... the 66th Annual Meeting of the American Academy ... ... AGI Dermatics presented,clinical research that indicates the 8-oxo-guanine DNA glycosylase (OGG1),encapsulated ... DNA repair, reducing MMP-1 secretion and increasing,collagen production in UV irradiated ...
... Uroplasty, Inc. (Amex:,UPI), a medical device company ... for the treatment of voiding dysfunction,announced today ... minimally invasive nerve stimulation device, designed for,office-based ... be,featured in three presentations at the Society ...
... Feb. 11 /PRNewswire-FirstCall/ - Neurochem Inc. (NASDAQ:,NRMX; TSX: ... 2008, Dr.,Francesco Bellini, Neurochem,s Chairman, President and Chief ... of the new,nutraceutical business, will present Neurochem,s strategy ... be held at the Waldorf-Astoria, in New York,(NY). ...
... bedside manner as better informed patients make ever-increasing demands ... in clinical decisions that directly affect their care. ... Related Research, Dr. J. Bohannon Mason of the Orthocarolina ... at the changes in society, the population and technology ...
... incidence of malignancy, so women with this condition can ... to a new study by a team of researchers ... A fibroadenoma is a benign growth of the breast ... usually associated with breast cancer, and are often diagnosed ...
... 2008 Researchers at Pulmonary Associates today announced ... for Emphysema) Trial, an international, multi-center clinical trial ... a new, minimally invasive option for those suffering ... airway bypass, a catheter-based bronchoscopic procedure designed to ...
Cached Medicine News:Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 2Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 3Health News:Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium 2Health News:Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live 2Health News:Doctor who? Are patients making clinical decisions? 2Health News:Study finds patients with complex fibroadenomas can avoid surgery 2Health News:Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema 2
(Date:7/30/2015)... ROCHELLE PARK, N.J. , July 30, 2015 /PRNewswire/ ... is voluntarily recalling one lot of Hydrochlorothiazide tablets 25 ... has been initiated as a precautionary measure due to ... bottle of the product. The risk ... a Hydrochlorothiazide tablet is the increased probability of experiencing ...
(Date:7/30/2015)... -- Amgen (NASDAQ: AMGN ) today announced the appointment of ... Pincus LLC, to the Amgen Board of Directors. ... and the deep, global experience he brings in the biopharmaceuticals ... , chairman and chief executive officer of Amgen. "Fred,s breadth of ... Mr. Hassan has been Partner and Managing Director ...
(Date:7/30/2015)... , July 30, 2015  Growth of the ... as they bring former prescription users to the OTC ... Kline forecasts robust Rx-to-OTC switch activity over the ... emerging along with many new brands entering the market ... over the next five years (even those with low ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... N.J., Sept. 13, 2011 BD (Becton, Dickinson and ... medical technology company, today announced a commitment to Pink ... and private investments in global health to combat cervical ... Institute, the President,s Emergency Plan for AIDS Relief (PEPFAR), ...
... Calif., Sept. 13, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Officer of BioMarin, will present a company update at the ... September 20, 2011 at 12:30 p.m. ET.   ... conference call via the investor section of the BioMarin website, ...
Cached Medicine Technology:BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 2BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 3BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® 4BioMarin to Present at the UBS Global Life Sciences Conference 2
... comfortable, and you will too., ,To ... to avoid the knotty problems associated with ... consider the Dale® Tracheostomy Tube Holder. Available ... fastener tabs of the Dale® Tracheostomy Tube ...
... Designed for ease of use and patient ... smooth edges for comfort and is available ... to a perfect fit. For hard to ... trach collar to your specifications. Don't just ...
... Percutaneous Dilation Tracheostomy Kits allow ... tracheostomy tube using the widely ... of a single-stage curved dilator. ... without the Portex® Blue Line ...
... Per-fit™ flexible PVC tube with a tapered ... designed to reduce insertion force and more ... kit s unique obturator/dilator design is engineered ... an easier transition through the tissue into ...
Medicine Products: